Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking method to diabetes management. These innovative therapies operate by mimicking the inherent actions of GLP-1, a hormone produced by the https://pr6bookmark.com/story20964163/the-emerging-role-of-glp-1-receptor-agonists-in-diabetes-management